Catalyst Wire Dossier Catalyst Wire Dossier

NanoFlu

recombinant trivalent nanoparticle influenza vaccine · Novavax
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NanoFlu, covering 2022-12-21 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Pivotal Trial of NanoFlu™ in Older Adults [Phase 3]

See pricing